nach oben

Erschienen in:

01.08.2022 | Case report

Surgical removal of giant pelvic liposarcoma after preoperative transcatheter arterial embolization

verfasst von: Yuto Maeda, Yuji Miyamoto, Yukiharu Hiyoshi, Kojiro Eto, Masaaki Iwatsuki, Shiro Iwagami, Yoshifumi Baba, Naoya Yoshida, Hideo Baba

Erschienen in: International Cancer Conference Journal | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Liposarcoma includes tumors with a wide range of malignancies, from mostly benign to malignant. We report a case of a 73 year-old man who was admitted for urination and defecation disorder. Contract computed tomography (CT) revealed a mass of approximately 21 cm occupying the pelvis, bladder, ureter, prostate, and rectum being compressed by the tumor. Since intraoperative mass bleeding was predicted, we embolized the tumor nutrition artery and performed a total pelvic exenteration. Regarding the course of the operation, SSI and pelvic infection were developed after the operation. The patient was discharged 21 days after surgery. Moreover, there is no evidence of local recurrence and distant metastasis at 18 months after surgery. Furthermore, in giant pelvic liposarcoma, it is useful to identify a nutritional artery of a giant tumor by angiography before surgery, and surgical resection can be safely done by performing preoperative transcatheter arterial embolization.

Mettlin C, Priore R, Rao U, Gamble D, Lane W, Murphy P (1982) Results of the national soft-tissue sarcoma registry. J Surg Oncol 19(4):224–227. https://doi.org/10.1002/jso.2930190410CrossRefPubMed

Bonello VA, Bhangu A, Fitzgerald JE, Rasheed S, Tekkis P (2014) Intraoperative bleeding and haemostasis during pelvic surgery for locally advanced or recurrent rectal cancer: a prospective evaluation. Tech Coloproctol 18(10):887–893. https://doi.org/10.1007/s10151-014-1150-zCrossRefPubMed

Chouairy CJ, Abdul-Karim FW, MacLennan GT (2007) Retroperitoneal liposarcoma. J Urol 177(3):1145. https://doi.org/10.1016/j.juro.2006.12.006CrossRefPubMed

Hosaka A, Masaki Y, Yamasaki K, Aoki F, Sugizaki K, Ito E (2008) Retroperitoneal mixed-type liposarcoma showing features of four different subtypes. Am Surg 74(12):1202–1205CrossRef

Sheffield BS, Nielsen TO (2013) Myxoid liposarcoma in a 91 year-old patient. Mol Cytogenet 6(1):50. https://doi.org/10.1186/1755-8166-6-50CrossRefPubMedPubMedCentral

Tseng WW, Seo HJ, Pollock RE, Gronchi A (2018) Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma. J Surg Oncol 117(1):7–11. https://doi.org/10.1002/jso.24888CrossRefPubMed

Feitosa MR, de Freitas LF, Filho AB, Nakiri GS, Abud DG, Landell LM, Brunaldi MO, da Rocha JJR, Feres O, Parra RS (2020) Preoperative rectal tumor embolization as an adjunctive tool for bloodless abdominoperineal excision: a case report. World J Clin Oncol 11(12):1070–1075. https://doi.org/10.5306/wjco.v11.i12.1070CrossRefPubMedPubMedCentral

Tseng WW, Wang SC, Eichler CM, Warren RS, Nakakura EK (2011) Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures. World J Surg Oncol 9:143. https://doi.org/10.1186/1477-7819-9-143CrossRefPubMedPubMedCentral

Yasumoto T, Yamamoto T, Tomimaru Y, Ide Y, Matsunaga H, Ikeda N, Maruyama K, Yokouchi H, Okada K, Ota H, Kinuta M, Murata K (2007) Transcatheter arterial embolization for the continuous bleeding from duodenal carcinoma–a case report. Gan Kagaku Ryoho 34(12):2141–2143

10.

Johnstone C, Rich SE (2018) Bleeding in cancer patients and its treatment: a review. Ann Palliat Med 7(2):265–273. https://doi.org/10.21037/apm.2017.11.01CrossRefPubMed

11.

Seki A, Shimono C (2017) Transarterial chemoembolization for management of hemoptysis: initial experience in advanced primary lung cancer patients. Jpn J Radiol 35(9):495–504. https://doi.org/10.1007/s11604-017-0659-2CrossRefPubMed

12.

Chen Y, Yang Y, Xu WJ, Xin YJ, Wang YN, Zhou X, Li X (2020) Clinical application of interventional embolization in tumor-associated hemorrhage. Ann Transl Med 8(6):394. https://doi.org/10.21037/atm.2020.03.69CrossRefPubMedPubMedCentral

13.

Qiao Z, Jia N, He Q (2015) Does preoperative transarterial embolization decrease blood loss during spine tumor surgery? Interv Neuroradiol 21(1):129–135. https://doi.org/10.15274/inr-2014-10091CrossRefPubMedPubMedCentral

14.

Aiba T, Uehara K, Tsukushi S, Yoshino Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M (2017) Perineal alveolar soft part sarcoma treated by laparoscopy-assisted total pelvic exenteration combined with pubic resection. Asian J Endosc Surg 10(2):198–201. https://doi.org/10.1111/ases.12342CrossRefPubMed

15.

Guo Y, Chang E, Bozkurt M, Park M, Liu D, Fu JB (2018) Factors affecting hospital length of stay following pelvic exenteration surgery. J Surg Oncol 117(3):529–534. https://doi.org/10.1002/jso.24878CrossRefPubMed

16.

Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, de Wilt JH (2009) Total pelvic exenteration for primary and recurrent malignancies. World J Surg 33(7):1502–1508. https://doi.org/10.1007/s00268-009-0066-7CrossRefPubMedPubMedCentral

17.

Kuhrt MP, Chokshi RJ, Arrese D, Martin EW Jr (2012) Retrospective review of pelvic malignancies undergoing total pelvic exenteration. World J Surg Oncol 10:110. https://doi.org/10.1186/1477-7819-10-110CrossRefPubMedPubMedCentral

18.

Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S (2003) Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum 46(4):474–480. https://doi.org/10.1007/s10350-004-6585-2CrossRefPubMed

19.

Vermaas M, Ferenschild FT, Verhoef C, Nuyttens JJ, Marinelli AW, Wiggers T, Kirkels WJ, Eggermont AM, de Wilt JH (2007) Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 33(4):452–458. https://doi.org/10.1016/j.ejso.2006.09.021CrossRefPubMed

20.

Miyamoto Y, Akiyama T, Sakamoto Y, Tokunaga R, Ohuchi M, Shigaki H, Kurashige J, Iwatsuki M, Baba Y, Yoshida N, Baba H (2016) Omental flap after pelvic exenteration for pelvic cancer. Surg Today 46(12):1471–1475. https://doi.org/10.1007/s00595-016-1348-yCrossRefPubMed

Titel: Surgical removal of giant pelvic liposarcoma after preoperative transcatheter arterial embolization
verfasst von: Yuto Maeda
Yuji Miyamoto
Yukiharu Hiyoshi
Kojiro Eto
Masaaki Iwatsuki
Shiro Iwagami
Yoshifumi Baba
Naoya Yoshida
Hideo Baba
Publikationsdatum: 01.08.2022
Verlag: Springer Nature Singapore
Erschienen in: International Cancer Conference Journal / Ausgabe 4/2022
Elektronische ISSN: 2192-3183
DOI: https://doi.org/10.1007/s13691-022-00560-z

A case of recurrent refractory cervical primary histiocytic sarcoma treated with pembrolizumab

Case report

Systematic review and meta-analysis of reports of patients with gastric cancer aged 80 years and older

Review article

Pancreatic-pleural fistula from tail pseudocyst in a patient with pancreatic head cancer: a case report

Case report

Eosinophilic cystitis mimicking hemorrhagic cystitis in relapsed follicular lymphoma

Case report

Dabrafenib plus trametinib treatment for a patient with BRAF V600E-mutated large-cell lung carcinoma and a poor performance status

Case report

Long-term treatment with ALK inhibitors for postoperative recurrence of ALK-rearranged lung cancer

Case report

Neu im Fachgebiet Onkologie

ctDNA erkennt minimale Resterkrankung beim Melanom

25.04.2025
Tumormarker
Nachrichten

Die Diagnose einer minimalen Resterkrankung mithilfe zirkulierender Tumor-DNA könnte (ctDNA) auch das Management von Patientinnen und Patienten mit Melanomen im Stadium III bereichern, wie Ergebnisse einer Studie nahelegen – auch wenn die Methode noch nicht perfekt funktioniert.

Höhere Dosis von Dexamethason senkt Überlebenschancen

25.04.2025
Zerebrale Metastasen
Nachrichten

Personen mit Hirnmetastasen, die perioperativ höhere kumulative Dosen von Dexamethason erhalten, haben eine schlechtere Prognose. Um die Ergebnisse zu verbessern, bedarf es strengerer Dosierungsschemata.

Ringen um den richtigen Umgang mit Zufallsbefunden

24.04.2025
DGP 2025
Kongressbericht

Wenn 2026 in Deutschland das Lungenkrebsscreening mittels Low-Dose-Computertomografie (LDCT) eingeführt wird, wird es auch viele Zufallsbefunde ans Licht bringen. Das birgt Chancen und Risiken.

Bald 5% der Krebserkrankungen durch CT verursacht

23.04.2025
Computertomografie
Nachrichten

Die jährlich rund 93 Millionen CTs in den USA könnten künftig zu über 100.000 zusätzlichen Krebserkrankungen führen, geht aus einer Modellrechnung hervor. Damit würde eine von 20 Krebserkrankungen auf die ionisierende Strahlung bei CT-Untersuchungen zurückgehen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Surgical removal of giant pelvic liposarcoma after preoperative transcatheter arterial embolization

Abstract

Weitere Artikel der Ausgabe 4/2022

A case of recurrent refractory cervical primary histiocytic sarcoma treated with pembrolizumab

Systematic review and meta-analysis of reports of patients with gastric cancer aged 80 years and older

Pancreatic-pleural fistula from tail pseudocyst in a patient with pancreatic head cancer: a case report

Eosinophilic cystitis mimicking hemorrhagic cystitis in relapsed follicular lymphoma

Dabrafenib plus trametinib treatment for a patient with BRAF V600E-mutated large-cell lung carcinoma and a poor performance status

Long-term treatment with ALK inhibitors for postoperative recurrence of ALK-rearranged lung cancer

Neu im Fachgebiet Onkologie

ctDNA erkennt minimale Resterkrankung beim Melanom

Höhere Dosis von Dexamethason senkt Überlebenschancen

Ringen um den richtigen Umgang mit Zufallsbefunden

Bald 5% der Krebserkrankungen durch CT verursacht

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten